2.05
price down icon4.21%   -0.09
after-market 시간 외 거래: 2.05
loading
전일 마감가:
$2.14
열려 있는:
$2.13
하루 거래량:
206.40K
Relative Volume:
0.49
시가총액:
$191.75M
수익:
-
순이익/손실:
$1.60M
주가수익비율:
68.33
EPS:
0.03
순현금흐름:
$-62.91M
1주 성능:
+14.53%
1개월 성능:
+28.93%
6개월 성능:
+43.36%
1년 성능:
+13.26%
1일 변동 폭
Value
$2.005
$2.135
1주일 범위
Value
$1.74
$2.31
52주 변동 폭
Value
$1.13
$2.38

Compugen Ltd Stock (CGEN) Company Profile

Name
명칭
Compugen Ltd
Name
전화
-
Name
주소
-
Name
직원
74
Name
트위터
@CompugenLtd
Name
다음 수익 날짜
2025-05-19
Name
최신 SEC 제출 서류
Name
CGEN's Discussions on Twitter

Compare CGEN vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CGEN
Compugen Ltd
2.05 200.17M 0 1.60M -62.91M 0.03
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.82 121.40B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
764.93 83.25B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
728.11 46.39B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.51 43.41B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
292.94 33.09B 5.36B 287.73M 924.18M 2.5229

Compugen Ltd Stock (CGEN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2026-01-07 개시 H.C. Wainwright Buy
2025-01-13 개시 Oppenheimer Outperform
2022-08-05 다운그레이드 Jefferies Buy → Hold
2020-05-26 재개 JMP Securities Mkt Outperform
2020-05-13 개시 Stifel Buy
2020-05-07 개시 SVB Leerink Outperform
2020-04-22 개시 ROTH Capital Buy
2020-03-24 개시 SunTrust Buy
2020-01-16 개시 Cantor Fitzgerald Overweight
2018-03-29 개시 Oppenheimer Outperform
2016-02-01 재개 Oppenheimer Outperform
2015-10-15 개시 FBR Capital Outperform
2015-04-23 재개 Jefferies Buy
2015-04-21 개시 Oppenheimer Outperform
2014-02-07 개시 MLV & Co Buy
2009-12-28 재확인 Cantor Fitzgerald Buy
2009-07-29 개시 Cantor Fitzgerald Buy
모두보기

Compugen Ltd 주식(CGEN)의 최신 뉴스

pulisher
Mar 04, 2026

BillionToOne Stock at $89: Why a New $19.1 Million Position Could Matter Now - AOL.com

Mar 04, 2026
pulisher
Mar 04, 2026

3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade - AOL.com

Mar 04, 2026
pulisher
Mar 04, 2026

Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus

Mar 04, 2026
pulisher
Mar 03, 2026

Why Tempus AI Stock Is Up Today — And What to Watch Before Next Week’s Earnings - AOL.com

Mar 03, 2026
pulisher
Mar 03, 2026

Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com

Mar 03, 2026
pulisher
Mar 03, 2026

Compugen (CGEN) Quarterly Loss Near US$7 Million Tests Bullish Profitability Narrative - simplywall.st

Mar 03, 2026
pulisher
Mar 02, 2026

Compugen (CGEN) Q4 2025 Earnings Call Transcript - The Globe and Mail

Mar 02, 2026
pulisher
Mar 02, 2026

From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer - AOL.com

Mar 02, 2026
pulisher
Mar 02, 2026

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen earnings beat by $0.68, revenue topped estimates - Investing.com South Africa

Mar 02, 2026
pulisher
Mar 02, 2026

Chegg Earnings: Big Quarter Sends Shares Higher - AOL.com

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen: Non-Dilutive Funding For Rilvegostomig Obtained And GS-0321 Advancement (CGEN) - Seeking Alpha

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen Q4 2025 Earnings Call Transcript - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 02, 2026
pulisher
Mar 02, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 02, 2026
pulisher
Mar 02, 2026

What Smart Money Loves About Lilly - AOL.com

Mar 02, 2026
pulisher
Mar 02, 2026

Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake - AOL.com

Mar 02, 2026
pulisher
Mar 02, 2026

Earnings call transcript: Compugen Q4 2025 sees earnings beat, stock surges - Investing.com Nigeria

Mar 02, 2026
pulisher
Mar 02, 2026

CGEN: 2025 saw a cash runway extension, profitability, and global clinical trial progress - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

CGEN: 2025 saw strong revenue growth, a return to profitability, and extended cash runway into 2029 - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen: Overview of Fourth Quarter Financial Results - Bitget

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen Extends Cash Runway to 2029 and Swings to Profit on AstraZeneca Deal and Clinical Progress - TipRanks

Mar 02, 2026
pulisher
Mar 02, 2026

Partnership payments lift Compugen (NASDAQ: CGEN) to 2025 profit - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

COMPUGEN ($CGEN) Releases Q4 2025 Earnings - Quiver Quantitative

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen stock jumps 5% on fourth quarter earnings beat - Investing.com

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen: Q4 Earnings Snapshot - marketscreener.com

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen : Corporate Presentation - marketscreener.com

Mar 02, 2026
pulisher
Mar 02, 2026

Earnings Breakdown: Compugen Q4 - Benzinga

Mar 02, 2026
pulisher
Mar 02, 2026

CGEN: Profitability achieved in 2025, driven by AstraZeneca deal and robust clinical progress - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen (Nasdaq: CGEN) swings to 2025 profit, extends cash runway to 2029 - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Compugen Reports Fourth Quarter and Full Year 2025 Results - Yahoo Finance

Mar 02, 2026
pulisher
Feb 28, 2026

Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29% - AOL.com

Feb 28, 2026
pulisher
Feb 27, 2026

Uncovering Potential: Compugen's Earnings Preview - Benzinga

Feb 27, 2026
pulisher
Feb 27, 2026

Compugen Ltd expected to post earnings of 5 cents a shareEarnings Preview - TradingView

Feb 27, 2026
pulisher
Feb 27, 2026

This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition - AOL.com

Feb 27, 2026
pulisher
Feb 27, 2026

Compugen Ltd (CGEN) Q4 2025: Everything You Need To Know Ahead O - GuruFocus

Feb 27, 2026
pulisher
Feb 27, 2026

MSN Money - MSN

Feb 27, 2026
pulisher
Feb 27, 2026

Compugen CEO Highlights COM701 Ovarian Cancer MAIA Trial, AstraZeneca and Gilead Updates at Oppenheimer Conf - Defense World

Feb 27, 2026
pulisher
Feb 26, 2026

Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% - AOL.com

Feb 26, 2026
pulisher
Feb 26, 2026

Compugen at Oppenheimer Conference: Strategic Insights on Partnerships - Investing.com India

Feb 26, 2026
pulisher
Feb 25, 2026

Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million - AOL.com

Feb 25, 2026
pulisher
Feb 25, 2026

This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges - AOL.com

Feb 25, 2026
pulisher
Feb 24, 2026

Here's Why Grail Stock Bounced Back 16% Today - AOL.com

Feb 24, 2026
pulisher
Feb 23, 2026

Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - AOL.com

Feb 23, 2026
pulisher
Feb 21, 2026

Is Compass Stock a Buy After Kanen Added 1.6 Million Shares to Its Position? - AOL.com

Feb 21, 2026
pulisher
Feb 21, 2026

Analyzing Sana Biotechnology (NASDAQ:SANA) & Compugen (NASDAQ:CGEN) - Defense World

Feb 21, 2026
pulisher
Feb 20, 2026

Exelixis: The Cash‑Generating Biotech That I Think Deserves a Closer Look in 2026 - AOL.com

Feb 20, 2026
pulisher
Feb 20, 2026

Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash - AOL.com

Feb 20, 2026

Compugen Ltd (CGEN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
자본화:     |  볼륨(24시간):